Tenidap – 5 mg

Brand:
Cayman
CAS:
120210-48-2
Storage:
-20
UN-No:
Non-Hazardous - /

Tenidap is a COX-1 selective non-steroidal anti-inflammatory drug (IC50s = 30 µM for COX-1, COX-2, and 5-lipoxygenase (5-LO), respectively).{5386} It has anti-inflammatory and antirheumatic properties.{5386,34222} In vitro, it inhibits prostaglandin D2 (PGD2), leukotriene B4 (LTB4), and prostaglandin E2 (PGE2) synthesis (IC50s = 0.02, 18, and 32 µM, respectively).{34224,34225} Tenidap also reversibly and dose-dependently activates hKir2.3 channels in CHO cells (EC50 = 402 nM) and inhibits fatty acid amide hydrolase (FAAH) activity.{34223,25933} A formulation containing tenidap was not approved for rheumatoid and osteoarthritis by the FDA due to adverse effects, including bone mineralization loss, as well as liver and kidney toxicity.  

 

Available on backorder

SKU: - Category:

Description

A COX-1 selective NSAID (IC50s = 30 µM for COX-1, COX-2, and 5-LO, respectively); inhibits PGD2, LTB4, and PGE2 synthesis (IC50s = 0.02, 18, and 32 µM, respectively); activates hKir2.3 channels in CHO cells (EC50 = 402 nM); inhibits FAAH activity


Formal name: (3Z)-5-chloro-2,3-dihydro-3-(hydroxy-2-thienylmethylene)-2-oxo-1H-indole-1-carboxamide

Synonyms:  CP 66,248

Molecular weight: 320.8

CAS: 120210-48-2

Purity: ≥98%

Formulation: A crystalline solid


Product Type|Biochemicals|Small Molecule Inhibitors|Cyclooxygenases||Product Type|Biochemicals|Small Molecule Inhibitors|Fatty Acid Metabolism||Research Area|Immunology & Inflammation|Autoimmunity|Rheumatoid Arthritis||Research Area|Immunology & Inflammation|Inflammatory Lipid Mediators|Leukotrienes||Research Area|Immunology & Inflammation|Inflammatory Lipid Mediators|Prostaglandins